Skip to content

诺信公司

US · NDSN #983 按市值排名 上市于 1970
322.31 -6.49 -1.97%
实时 - 追踪5344个代码 - 心跳于9秒前 · 2026-10-16 19:31

✦ 量化股权信号 计算方式说明

涨跌不一/平稳
  • 最近一期（2026/Q3）披露持股的机构数量减少了2家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
77.51% -0.01pp
机构数量
876 -2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund64.86%
Individual/Insider5.64%
Public Company3.49%
Hedge Fund2.66%
Government Pension Fund2.23%
Private Company2.15%
Sovereign Wealth Fund1.38%
Family Office/Trust0.31%
Insurance Company0.24%
Other17.04%

主要股东 截至 2026-06-30

BlackRock 7.43% · 4.14M 股
Vanguard Capital Management, LLC 6.76% · 3.76M 股
State Street Global Advisors 5.34% · 2.98M 股
Jennifer Savage 5.29% · 2.95M 股
Vanguard Portfolio Management, LLC 4.24% · 2.36M 股
Nord family descendants 3.75% · 2.09M 股
Geode Capital Management, LLC 3.42% · 1.91M 股
Kayne Anderson Rudnick Investment Management, LLC 3.08% · 1.71M 股
Eaton Vance Management 2.06% · 1.14M 股
Invesco Capital Management LLC 1.98% · 1.10M 股
Norges Bank Investment Management 1.28% · 715.04K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 25次买入 · 25次卖出

姓名职务持股比例
Sundaram Nagarajan Chief Executive Officer 0.13%
James DeVries Executive Vice President of Continuous Improvement 0.09%
Victor Richey Independent Director 0.04%
Frank Jaehnert Independent Director 0.03%
Ginger Jones Independent Director 0.01%
John DeFord Independent Director 0.01%
Srinivas Subramanian -- 0.01%
Jennifer A. Parmentier Independent Director 0.01%
Jennifer McDonough General Counsel 0.01%
Stephen Lovass Executive Vice President of Medical and Fluid Solutions 0.00%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-14 Joseph Rutledge Chief Accounting Officer Open Market Disposition -684 $309.38
2026-09-01 Milton Morris Independent Director Open Market Disposition -156 $316.63
2026-08-31 Justin Hall Executive Vice President of Medical & Fluid Solutions Sale to Issuer -118 $314.40
2026-08-26 Jennifer McDonough General Counsel Open Market Disposition -260 $336.00
2026-08-25 Daniel Hopgood Chief Financial Officer Derivative Exercise and Sale -1,329 $209.73–334.29
2026-07-30 John DeFord Independent Director Other Acquisition +84 $297.78
2026-07-30 Christopher Mapes Director Other Acquisition +42 $297.78
2026-07-30 Joseph Rutledge Chief Accounting Officer Sale to Issuer -274 $297.78
2026-06-03 James DeVries Executive Vice President of Continuous Improvement Intent to Sell (Form 144) -6,600 $290.00
2026-05-31 Daniel Hopgood Chief Financial Officer Sale to Issuer -148 $281.31
2026-04-30 Annette Clayton Chairwoman Other Acquisition +270 $283.20
2026-04-29 John DeFord Independent Director Other Acquisition +87 $288.45
2026-04-29 Christopher Mapes Director Other Acquisition +43 $288.45
2026-04-16 Srinivas Subramanian -- Automatic Disposition -1,200 $280.00
2026-04-16 Srinivas Subramanian -- Derivative Exercise and Sale -1,900 $107.65–280.00
2026-04-15 James DeVries Executive Vice President of Continuous Improvement Sale to Issuer -198 $275.28
2026-04-14 Milton Morris Independent Director Open Market Disposition -245 $273.87
2026-04-07 Justin Hall Executive Vice President of Medical & Fluid Solutions Open Market Disposition -716 $275.82
2026-02-26 Sarah Siddiqui Executive Vice President Sale to Issuer -30 $293.44
2026-02-23 Joseph Kelley Chief Financial Officer Intent to Sell (Form 144) -8,725 $293.04

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:31:26 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

诺信公司 讨论区 0 条评论

发表评论